STOCK TITAN
  1. Home
  2. Sec-filings
  3. LH
  4. [Form 4] LABCORP HOLDINGS INC. Insider Trading Activity

Labcorp executive granted 1,500 RSUs on Sept. 1

Executive Bryan T. Vaughn received a new equity award of 1,500 RSUs that vests over three years.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. (symbol: LH) is the issuer of record for a Form 4 filing submitted to the SEC. Vaughn Bryan T reported acquisition or exercise transactions in this Form 4 filing.

LABCORP HOLDINGS INC. (LH) reported that executive officer Bryan T. Vaughn, EVP and President, Diagnostics, received a grant of 1,500 Restricted Stock Units on September 1, 2026. Each unit represents the contingent right to receive one share of common stock and vests in three equal annual installments beginning on September 1, 2027. Following this award, Vaughn holds an aggregate of 5,204 Restricted Stock Units, all reported as directly owned.

Positive

  • None.

Negative

  • None.
Insider Vaughn Bryan T
Role EVP and President, Diagnostics
Type Security Shares Price Value
Grant/Award Restricted Stock Unit F1, F2, F3 1,500 $0.00 $0.00
Holdings After Transaction: Restricted Stock Unit — 5,204 contracts (Direct)
Footnotes (3)
  1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  2. F2. The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
  3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Restricted Stock Units granted 1,500 units Grant to Bryan T. Vaughn on September 1, 2026
Grant price per unit $0.00 per unit Reported for the 1,500 Restricted Stock Units granted
Underlying common shares per RSU 1 share per unit Each RSU represents the contingent right to receive one share of common stock
Post-transaction RSU holdings 5,204 units Aggregate Restricted Stock Units held by Bryan T. Vaughn after the grant
Vesting installments 3 equal annual installments Vesting schedule beginning on September 1, 2027 for the 1,500 RSUs
Restricted Stock Unit financial
"Each Restricted Stock Unit represents the contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents the contingent right to receive one share of Labcorp Holdings Inc."
vest financial
"The Restricted Stock Units vest in three equal annual installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

What insider transaction did LABCORP (LH) report for Bryan T. Vaughn?
LABCORP reported that Bryan T. Vaughn, EVP and President, Diagnostics, received a grant of 1,500 Restricted Stock Units on September 1, 2026, as a compensation-related award reported at a price of $0.00 per unit.

What do the 1,500 Restricted Stock Units granted at LH represent?
Each of the 1,500 Restricted Stock Units granted to Bryan T. Vaughn represents the contingent right to receive one share of Labcorp Holdings Inc. common stock, subject to the vesting conditions described in the award.

What is the vesting schedule for Bryan T. Vaughn’s new RSUs at LH?
The 1,500 Restricted Stock Units granted to Bryan T. Vaughn vest in three equal annual installments, with vesting beginning on September 1, 2027. One-third of the award vests each year over this three-year period.

How many Restricted Stock Units does Bryan T. Vaughn hold after this LH transaction?
After the September 1, 2026 grant, Bryan T. Vaughn holds an aggregate of 5,204 Restricted Stock Units in Labcorp Holdings Inc., as disclosed in the filing. These holdings are reported as directly owned equity awards.

Was the LH Form 4 transaction by Bryan T. Vaughn under a Rule 10b5-1 plan?
No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed for this Form 4, and there is no footnote stating that the 1,500 RSU grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vaughn Bryan T
(Last)(First)(Middle)
531 SOUTH SPRING STREET
(Street)
BURLINGTON NORTH CAROLINA 27215
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and President, Diagnostics
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)09/01/2026A1,500 (2) (2)Common Stock1,500$05,204(3)D
Explanation of Responses:
1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
/s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR